Finance

Lists
4516:TYO
Nippon Shinyaku Co Ltd
3 410,00 JP¥
-1,22%
(-42,00) 1D
29 սեպ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4516...
Open
3 450 JP¥
High
3 459 JP¥
Low
3 387 JP¥
Mkt. cap
239,56 մլրդ
Avg. vol.
394,46 հզր
Volume
562,40 հզր
Dividend
3,64%
Quarterly dividend
31 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
7,27
52-wk high
6 529 JP¥
52-wk low
3 187 JP¥
EPS
469 JP¥
Shares outstanding
67,35 մլն
No. of employees
2 հզր
Open
3 450 JP¥
High
3 459 JP¥
Low
3 387 JP¥
Mkt. cap
239,56 մլրդ
Avg. vol.
394,46 հզր
Volume
562,40 հզր
Dividend
3,64%
Quarterly dividend
31 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
7,27
52-wk high
6 529 JP¥
52-wk low
3 187 JP¥
EPS
469 JP¥
Shares outstanding
67,35 մլն
No. of employees
2 հզր
Profile
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that markets prescription drugs and functional foods. Nippon Shinyaku has developed treatments such as viltolarsen for Duchenne muscular dystrophy. Wikipedia
About Nippon Shinyaku Co Ltd
CEO-
Employees2,31 հզր
Founded01 հոկ, 1919 թ.
Headquarters-
Sector-
Websitenippon-shinyaku.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
40,10 մլրդ
47,49 մլրդ
43,64 մլրդ
49,07 մլրդ
Cost of goods sold
12,68 մլրդ
16,68 մլրդ
15,45 մլրդ
17,73 մլրդ
Cost of revenue
12,68 մլրդ
16,68 մլրդ
15,45 մլրդ
17,73 մլրդ
Research and development expenses
8,45 մլրդ
8,40 մլրդ
13,68 մլրդ
9,20 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,36 մլրդ
11,35 մլրդ
10,89 մլրդ
11,08 մլրդ
Operating expense
17,92 մլրդ
18,06 մլրդ
27,55 մլրդ
19,03 մլրդ
Total operating expenses
30,60 մլրդ
34,73 մլրդ
43,00 մլրդ
36,75 մլրդ
Operating income
9,50 մլրդ
12,75 մլրդ
639,00 մլն
12,31 մլրդ
Other non operating income
1,00 մլն
-2,00 մլն
323,00 մլն
-1,00 մլն
EBT including unusual items
9,53 մլրդ
13,20 մլրդ
3,24 մլրդ
12,96 մլրդ
EBT excluding unusual items
9,53 մլրդ
13,20 մլրդ
3,35 մլրդ
12,96 մլրդ
Income tax expense
2,02 մլրդ
3,11 մլրդ
-642,00 մլն
2,85 մլրդ
Effective tax rate
21,19%
23,57%
-19,83%
22,00%
Other operating expenses
-888,00 մլն
-1,68 մլրդ
2,01 մլրդ
-1,24 մլրդ
Net income
7,50 մլրդ
10,08 մլրդ
3,88 մլրդ
10,11 մլրդ
Net profit margin
18,72%
21,23%
8,88%
20,60%
Earnings per share
-
-
-
-
Interest and investment income
82,00 մլն
464,00 մլն
119,00 մլն
689,00 մլն
Interest expense
-55,00 մլն
-19,00 մլն
-
-41,00 մլն
Net interest expenses
27,00 մլն
445,00 մլն
119,00 մլն
648,00 մլն
Depreciation and amortization charges
-
-
974,00 մլն
-
EBITDA
11,14 մլրդ
14,41 մլրդ
2,38 մլրդ
14,09 մլրդ
Gain or loss from assets sale
19,00 մլն
56,00 մլն
56,00 մլն
-473,00 մլն
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps